로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Licensing(5) Check out full-length Claudin 18.2, CD20 and more.
타깃 항목 지시 연구 단계 합작 수요
PD-1 BBS21008 Solid tumors such as lung cancer, gastric carcinoma, esophagus cancer, cervical cancer. Pre-clinical, CMC developing; Project transfer or co-development. (the project’s company is in the startup stage and seek external cooperation to accelate drug research and development.)
TIGIT BBS21003 NSCLC, SCLC, multiple myeloma, liver cancer, triple negative breast cancer, pancreatic cancer, etc. Cell line was confirmed, and cell line stability study was completed. The pilot production and toxicology study is being started. Project authorization, transfer or co-development.
PD-1 BLL202202 broad cancer Ready for CMC development License-out or co-development
TIM-3 BLL202201 Solid Tumor Phase 1 License-out or co-development
B7-H3 BDA202203 B7H3+ and PD-L1+/low cancer CMC development License-out or co-development
Antibody(32) Check out full-length Claudin 18.2, CD20 and more.
분자 제품번호 종류. 제품 설명 숙주 순도 특징. 사이즈 및 가격 비교
Rituximab RIB-Y37
Mouse
Anti-Rituximab Antibodies (AY37) (recommended for PK/PD) Hybridoma
Cetuximab CEB-Y29
Mouse
Anti-Cetuximab Antibodies (AY29) (recommended for PK/PD) Hybridoma
Cetuximab CEB-BY31
Mouse
Biotinylated Anti-Cetuximab Antibodies (AY31) (recommended for PK/PD) Hybridoma
Adalimumab ADB-Y23b
Mouse
Anti-Adalimumab Antibodies (AY23b) (recommended for PK/PD) HEK293
Bevacizumab BEB-BY13
Mouse
Biotinylated Anti-Bevacizumab Antibodies (AY13) (recommended for PK/PD) Hybridoma
Bevacizumab BEB-Y10
Mouse
Anti-Bevacizumab Antibodies (AY10) (MALS verified, recommended for PK/PD) Hybridoma
Trastuzumab TRB-Y1b
Mouse
Anti-Trastuzumab Antibodies (AY1b) (recommended for PK/PD) HEK293
Trastuzumab TRB-Y5b
Mouse
Anti-Trastuzumab Antibodies (AY5b) (recommended for PK/PD) HEK293
Total:222
1 2 3 4 5 6
Results Per Page

발전 건의

This web search service is supported by Google Inc.

totop